Objective: The preventable proportion of healthcare-associated infections (HAIs) may decrease over time as standards of care improve. We aimed to assess the proportion of HAIs prevented by multifaceted infection control interventions in different economic settings. Methods: In this systematic review and meta-analysis, we searched OVID Medline, EMBASE, CINAHL, PubMed, and The Cochrane Library for studies published between 2005 and 2016 assessing multifaceted interventions to reduce catheter-associated urinary tract infections (CAUTIs), central-line-associated bloodstream infections (CLABSIs), surgical site infections (SSIs), ventilator-associated pneumonia (VAP), and hospital-acquired pneumonia not associated with mechanical ventilation (HAP) in acute-care or long-term care settings. For studies reporting raw rates, we extracted data and calculated the natural log of the risk ratio and variance to obtain pooled risk ratio estimates. Results: Of the 5,226 articles identified by our search, 144 studies were included in the final analysis. Pooled incidence rate ratios associated with multifaceted interventions were 0.543 (95% confidence interval [CI], 0.445-0.662) for CAUTI, 0.459 (95% CI, 0.381-0.554) for CLABSI, and 0.553 (95% CI, 0.465-0.657) for VAP. The pooled rate ratio was 0.461 (95% CI, 0.389-0.546) for interventions aiming at SSI reduction, and for VAP reduction initiatives, the pooled rate ratios were 0.611 (95% CI, 0.414-0.900) for before-and-after studies and 0.509 (95% CI, 0.277-0.937) for randomized controlled trials. Reductions in infection rates were independent of the economic status of the study country. The risk of bias was high in 143 of 144 studies (99.3%). Conclusions: Published evidence suggests a sustained potential for the significant reduction of HAI rates in the range of 35%-55% associated with multifaceted interventions irrespective of a country's income level. The authors concluded that 30%-35% of most healthcareassociated infections (HAIs) were preventable with effective surveillance and control programs. Numerous studies have since examined interventions to reduce the most common HAIs: central-line-associated bloodstream infections (CLABSIs), catheterassociated urinary tract infections (CAUTIs), ventilator-associated pneumonia (VAP) and surgical site infection (SSI). Harbarth et al 2 performed a systematic literature review to describe multimodal intervention studies to give a crude estimate of the proportion of potentially preventable nosocomial infections almost 20 years later, in 2004. They concluded that great potential existed to decrease nosocomial infection rates, from a minimum reduction effect of 10% to a maximum effect of 70%, depending on the setting, study design, baseline infection rates, and type of infection. In 2011, a review by Umscheid et al 3 confirmed that as many as 65%-70% of cases of CLABSI and CAUTI and 55% of cases of VAP and SSI might be preventable with current evidence-based strategies, with CLABSI having the highest number of preventable deaths and the highest cost impact. Irrespective of these consistent numbers on reported preventable proportions of infections in the past, the effect of interventions that aim to further reduce HAIs may diminish over time as quality initiatives and infection control programs improve, especially in higher income settings-a phenomenon known as the law of diminishing returns.
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The authors concluded that 30%-35% of most healthcareassociated infections (HAIs) were preventable with effective surveillance and control programs. Numerous studies have since examined interventions to reduce the most common HAIs: central-line-associated bloodstream infections (CLABSIs), catheterassociated urinary tract infections (CAUTIs), ventilator-associated pneumonia (VAP) and surgical site infection (SSI). Harbarth et al 2 performed a systematic literature review to describe multimodal intervention studies to give a crude estimate of the proportion of potentially preventable nosocomial infections almost 20 years later, in 2004. They concluded that great potential existed to decrease nosocomial infection rates, from a minimum reduction effect of 10% to a maximum effect of 70%, depending on the setting, study design, baseline infection rates, and type of infection. In 2011, a review by Umscheid et al 3 confirmed that as many as 65%-70% of cases of CLABSI and CAUTI and 55% of cases of VAP and SSI might be preventable with current evidence-based strategies, with CLABSI having the highest number of preventable deaths and the highest cost impact. Irrespective of these consistent numbers on reported preventable proportions of infections in the past, the effect of interventions that aim to further reduce HAIs may diminish over time as quality initiatives and infection control programs improve, especially in higher income settings-a phenomenon known as the law of diminishing returns.
We therefore aimed to perform a systematic review and metaanalysis on the proportion of preventable HAIs among the adult patient population in different economic settings based on the literature published in 2005-2016.
Methods

Data sources and searches
For this systematic review and meta-analysis, we performed an electronic search of OVID Medline, EMBASE, CINAHL (The Cumulative Index to Nursing and Allied Health Literature), PubMed, and The Cochrane Library for articles published between January 1, 2005, and October 7, 2016, based on a previously defined protocol. The search strategy was developed with the help of an experienced librarian with expertise in literature searches for systematic reviews and meta-analyses. For the detailed search strategy, see Supplemental Table S1 .
Study selection
We included all quasi-experimental studies, cohort studies, casecontrol studies, and randomized controlled trials evaluating multifaceted interventions to reduce CAUTIs, CLABSIs, SSIs, VAP, and hospital-acquired pneumonia in nonventilated patients (HAP) in acute-care or long-term care settings that reported infection rates as an outcome. Interventions were considered multifaceted if 2 or more interventions (eg, education AND surveillance, preoperative skin decolonization AND changes in the preoperative skin disinfection protocol) with the aim of reducing HAIs were performed. Surveillance of HAIs or audits were only considered interventions if these measures were combined with feedback. There was no restriction by study site, country, or follow-up period. Only studies published in English were considered eligible. Studies were excluded if they were cases series, case reports, outbreak reports, or ecological studies; if they included patients <16 years of age; or if they investigated only 1 specific intervention measure.
Two authors (P.W.S. and S.P.K.) screened the title and abstract of each reference identified by the search and applied the inclusion criteria. For possibly relevant articles, the full-text article was reviewed independently by the 2 authors. Final inclusion of studies was determined by agreement of both reviewers and involvement of a third author (H.S.) in cases of discrepancy. After in-depth discussion of the different opinions, the authors agreed unanimously on the final classification and inclusion of all studies.
Data extraction and quality assessment
Two authors (P.W.S. and S.P.K.) independently extracted data from published reports. In the case of missing data, no attempts were made to contact study authors, and these articles were subsequently excluded. Data extraction was performed using a standardized data collection form. The reviewers extracted data on study design, population and setting, interventions tested, and outcome measurement. Countries were classified by economic income group according to the World Bank list of economies (March 2017 version). 4 The primary outcome measure was the proportion of infected patients or the infection rate. Data were extracted as proportions if results were only reported as probability of events or as rates per number of device days. If rates were not reported per number of device days but were only reported per number of patient days, the latter was extracted.
To assess methodological quality and risk of bias in randomized controlled studies and controlled before-and-after studies, included articles were examined for (1) generation of allocation sequence, (2) concealment of allocation, (3) similarity of baseline outcome measurement, (4) similarity of baseline characteristics, (5) addressing incomplete outcome data, (6) prevention of knowledge of allocated interventions, (7) protection against contamination, (8) freedom of selective outcome reporting, and (9) freedom from other risks of bias. 5, 6 For interrupted time-series analyses, we assessed (1) independency of other changes, (2) prespecification of the shape of the intervention effect, (3) likelihood of affection of data collection by the intervention, (4) appropriate analysis, (5) prevention of knowledge of the allocated intervention during the study, (6) addressing incomplete outcome data, (7) freedom of selective outcome reporting, and (8) freedom from other risk of bias. 5, 6 Because uncontrolled beforeand-after studies are generally considered low quality, no further quality assessment was performed for this type of study. 5 
Data synthesis and analysis
For studies reporting only aggregated data without the possibility to calculate raw numbers, no data synthesis was performed. For studies reporting raw rates, we calculated the natural log of the risk ratio and variance to meta-analyze the extracted data and to obtain pooled risk ratio estimates. Data synthesis was performed using STATA version 11.1 software (StataCorp, College Station, TX). Because heterogeneity was anticipated between studies, random effects models using the method of DerSimonian and Laird, with the estimate of heterogeneity being taken from the inverse-variance fixed-effect model (for meta-analysis of rates) or the Mantel-Haenszel model (for meta-analysis of proportions) were used for all analyses to obtain a summary estimate (incidence rate ratio [IRR] or rate ratio [RR] , as appropriate) of the average effect with its 95% confidence interval (CI). A continuity correction of 0.5 to the counts from both groups of the study were added where a study contained a zero count in either the control group or the intervention group. 5, 7 Statistical heterogeneity was initially inspected graphically in a forest plot. We quantified the degree of heterogeneity using the I 2 statistic and defined heterogeneitiy a priori as I 2 > 60%. Subgroup analyses for differences between country economic income categories were performed using fixed-effect models if criteria for heterogeneity were not met. P values <.05 were considered statistically significant.
Publication bias was investigated using a funnel plot in which the standard error of the effect estimate of each study was plotted against the estimate and was quantified using the Egger test.
Results
Study selection
The review process is summarized in Figure 1 . Of the 5,226 articles retrieved with our search strategy, 208 were retained for full-text review, and 144 studies met the inclusion criteria and were included in the systematic review and meta-analysis. Included studies are described in Table 1 . There were 138 quasi-experimental studies (95.8%): 1 controlled before-and-after study, 137 uncontrolled before-and-after studies. Compared to standard of care, multifaceted interventions were associated with a pooled IRR of 0.543 (95% CI, 0.445-0.662), with overall heterogeneity of I 2 = 78.9%. Significant reductions in CAUTI incidence could be observed in all country economic income groups, although differences between subgroups could not be explored due to high heterogeneity (Fig. 2) . The 7 studies reporting aggregated data on CAUTI rates demonstrated between 100% reduction and a statistically insignificant MRSA screening and decolonization, preoperative showering, hair removal with clippers, glucose control for diabetic patients, normothermia, antibiotic prophylaxis, CHG-alcohol for skin preparation, antiseptic impregnated incisive drapes, supplemental oxygen in early postoperative phase, process and outcome monitoring and feedback Table  S2) . 18, 19, 40, 59, 64, 96, 133 Publication bias was evident from visual inspection of the funnel plot ( Supplementary Fig. S1b ) and was confirmed using the Egger test (P = .002).
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Central-line-associated bloodstream infection
In total, 30 before-and-after studies reported raw data on infection rates and were available for meta-analysis ( Supplementary  Fig.  S2a ). 24, 30, 34, 42, 43, 52, 57, 58, 63, 66, 69, 74, 76, 82, 84, 87, 89, 92, 97, 102, 106, 108, 109, 111, 119, 123, 132, 137, 138, 151 The pooled IRR of these studies was 0.459 (95% CI, 0.381-0.554), with an overall heterogeneity of I 2 = 86.8%. Reductions in CLABSI incidence could be observed in all country economic income groups, although differences between subgroups could not be explored due to high heterogeneity (Fig. 3) . Changes in CLABSI rates ranged from a reduction of 100% to a statistically insignificant increase of 6% in 15 studies reporting aggregated data only (Supplementary  Table S3 ). 8, 12, 36, 38, 59, 60, 64, 99, 103, 107, 115, 125, 139, 143, 148 Visual inspection of the funnel plot ( Supplementary Fig. S2b ) and the Egger test (P = 0.071) revealed no publication bias.
Surgical site infections
Overall, 36 before-and-after studies and 1 RCT reported raw data on infection rates and were available for meta-analysis (Supplementary Fig. S3a ). [9] [10] [11] 14, 15, 17, 21, 23, 29, 37, 39, 51, 55, 56, 65, 67, 72, 77, 80, 86, 88, 91, 93, 94, 100, 104, 105, 110, 114, 117, 118, 124, 130, 134, 145, 147, 150 The pooled RR of the before-and-after studies was 0.461 (95% CI, 0.389-0.546), with an overall heterogeneity of I 2 = 66.4%. A significant increase of SSI rates associated with a multifaceted intervention (RR, 1.565; 95% CI, 1.015-2.412) was reported in 1 RCT. 134 Significant reductions in SSI rates could be observed in all country economic income groups, but differences between subgroups could not be explored due to high heterogeneity (Fig. 4) . Supplementary  Table S4 lists the 4 studies reporting aggregated SSI rates only. In these studies, SSI reductions ranged from 31% to 84%. 45, 68, 122, 139 Publication bias was evident from visual inspection of the funnel plot ( Supplementary Fig. S3b ) and was confirmed using the Egger test (P = .004).
Ventilator-associated pneumonia
Raw data from 17 before-and-after studies were used to calculate the pooled IRR for VAP ( Supplementary  Fig.  S4a) . 22, 25, 31, 33, 44, 54, 58, 62, 70, 76, 81, 85, 95, 98, 101, 102, 137 The pooled IRR of these studies was 0.553 (95% CI, 0.465-0.657), with an overall heterogeneity of I 2 = 81.0%. Significant reductions in VAP incidence could be observed in all country economic income groups, although differences between subgroups could not be explored due to high heterogeneity (Fig. 5) . Moreover, 5 before-and-after studies and 2 RCTs reported raw proportions of patients with VAP ( Supplementary Fig. S5a) . 47, 73, 112, 113, 121, 126, 141 All but 1 of these studies, which was conducted in a upper middle income country, 141 were performed in high income countries. The pooled RR (95% CI) of the before-and-after studies was 0.611 (95% CI, 0.414-0.900). The 2 RCTs showed a pooled RR of 0.509 (95% CI, 0.277-0.937).
121,141 Data from 22 studies with aggregated data for VAP are shown in Supplementary Table S5 Figures  S4b and S5b ) and the Egger test (P = .105 for studies reporting rates; P = .560 for studies reporting proportions) revealed no evidence for publication bias. 
Healthcare-associated pneumonia
Only 2 uncontrolled before-and-after studies on HAP met the inclusion criteria. 90, 146 One study showed an adjusted OR of 0.16 (95% CI, 0.01-0.94) associated with a multifaceted intervention for prevention of postoperative pneumonia. 90 Another study reported a significant reduction of 43.6% of HAP rates, from 0.78% (preintervention) to 0.44% (postintervention).
146
Study quality
The risk of bias in all but 1 of the included studies was high. Uncontrolled before-and-after studies were a priori defined to be at high risk of bias. All 5 randomized controlled trials and the controlled beforeand-after study were considered at high risk of bias because study participants and study personnel were unblinded throughout (Supplementary Table S6) .
43,50,60,120,134,141 Risk of bias was unclear in the remaining 1 interrupted time-series analysis. The proportion of HAIs that is preventable is still under debate. 3 Our observed ranges of reductions associated with the implementation of multfaceted, evidence-based interventions are in line with previous estimates. [1] [2] [3] Our results confirmed the findings by Harbarth et al 2 that the largest effect was attributed to interventions targeting CLABSI prevention. Interestingly, the avoidable proportion of HAI does not seem to decrease over time as would be predicted by the law of diminishing returns given the increasingly widespread availability and expected implementation of evidence-based practices for HAI reduction. 153 However, for an accurate comparison, these findings must be considered in the context of changes in epidemiology over time. From 1997 to 2008, an increase of the percentage of the elderly (≥65 years of age) population from 12% to 37% was described in the United States, and a similar increase of this elderly fraction in hospitalized patients was reported. 154 Increasing age is associated with a higher rate of hospitalization. 155 Furthermore, aging predisposes to the development of chronic diseases, increasing the likelihood of multimorbidity. 156 Later studies likely included a larger fraction of older and sicker patients-a vulnerable population prone to HAIs and increased morbidity and mortality resulting from HAIs. Therefore, it would seem that increasing implementation of evidence-based best practies has been met with global trends of aging and multimorbidity, which necessitate additional efforts to further reduce HAIs. Overall, the HAI target should likely be considered an ever-moving group of individuals at risk who enter and leave the healthcare system.
Our findings demonstrate that even in high income countries, where high adherence to current recommendations may be expected, there remains considerable room for improvment. The persistance of a 30%-50% potential reduction in HAI with the implementation of evidence-based strategies demonstrates that current recommendations have not been sufficiently implemented. Importantly, the quality of infection control measures cannot be inferred on country economic classification alone. However, due to the heterogeneity of studies included in our dataset and lack of information on process indicators, we were unable to determine whether the actual efforts to achieve a reduction of HAI differed between studies from different economies. Although many hospitals, particularly in high income settings, may claim that they adhere to current evidence-based standards, implementation science has demonstrated a large discrepancy between the intention to effect change by employing standard operating procedures and true implementation of such practices into daily practice.
157,158 On the other hand, our results may also indicate that there is room for improvement after implementation of basic infection control measures that reduce HAI rates to levels that do not attract further attention.
Our systematic review and meta-analysis included multifaceted interventions only. Another highly interesting, and until now unresolved, question concerns the individual contribution of the single components of bundled interventions. Although not addressed in the current study, more profound knowledge would help guide bundle development by focusing on the most efficient elements of these interventions.
The studies reviewed in this analysis only covered known measures for IPC. The evolution of risk related to the acquisition of HAIs in medicine, however, is unknown. On one hand, medical innovations may reduce the risk of HAIs due to less invasive techniques (eg, minimal invasive surgery or noninvasive ventilation). On the other hand, novel technologies allowing interventions on patient populations that were previously ineligible for certain treatments due to impaired health status may be associated with an increased risk of HAIs. Even factors that may be perceived as unmodifiable today may be alterable in the future. Therefore, continuous efforts in the field of IPC are needed to keep up with medical progress. Such efforts must consider not only extrinsic factors (including medical devices) but also intrinsic factors (ie, host and microbes). In the future, IPC should and will be integrated more intrinsically in all medical procedures. In addition to the medical duty to prevent harm to patients, recent literature further illustrates that infection prevention programs are cost-effective when factoring in the incremental costs of HAIs to hospitals. 3 This particularly applies to settings were complications are not reimbursed or even associated with penalizations.
159,160
The fact that we observed publication bias for studies on CAUTI and SSI and that risk of bias was high in 143 of 144 studies (99.3%) needs to be considered. An uncontrolled study design with before-and-after assessment of the intervention effect was used in most studies; thus, bias due to the influence of unmeasured extraneous factors that change over time cannot be excluded. Moreover, blinding was not performed in the 4 randomized controlled trials that were included, which may also have distorted the reported results. As in other fields of medicine, smaller intervention trials with negative results may remain unpublished. 161 The HAIs addressed in this systematic review and meta-analysis mainly consist of device-associated infections. These infections, however, represent only a fraction of all HAIs. Data about the preventable proportion of non-device-associated infections are scarce; only 2 studies on HAP were included in our study. Lastly, the clear majority of the included papers reported on a single HAI or on only 1 type of SSI, which indicates that even though the interventions are multifaceted, their focus is nevertheless narrow. Additional, higher-quality data are clearly required to guide prevention efforts from a governance perspective.
The preventable proportion of HAIs reported by this systematic literature review and meta-analysis of 35%-55% suggests that there remains much to be desired in terms of implementation of evidence-based best practices. Our study findings should motivate healthcare institutions that aim to improve quality of patient care and to reduce infection rates to develop their own customized, multifaceted strategies to improve patient outcomes. 
